“Dedicated Scleroderma Programs and
the Research they Conduct"
Monique Hinchcliff, MD, MS
Patient Education Forum - Yale University: 2020
About Dr. Hinchcliff:
Dr. Monique Hinchcliff is Director of Clinical and Translational Research for Rheumatology, Allergy & Immunology at the Yale School of Medicine and the Director of the Yale Scleroderma Program. She received her medical degree from the Rosalind Franklin University Chicago Medical School and completed her medicine residency at Norwalk Hospital in Connecticut. She completed rheumatology fellowship training at Northwestern University Feinberg School of Medicine in Chicago, IL while earning a Master of Science degree in Clinical Investigation. Her research program includes clinical, interventional and observational studies, with the goal of better understanding systemic sclerosis and identifying new and repurposed treatments for patients with systemic sclerosis. Clinically, Dr. Hinchcliff leads a team of multidisciplinary specialists with expertise in caring for patients with systemic sclerosis. Currently, her research is focused on determining the role of macrophages in fibrotic lung disease in patients with systemic sclerosis and identifying better outcomes for systemic sclerosis skin disease to improve clinical trial design.
Dr Hinchcliff is a member of the Scleroderma Foundation Tri-State Chapter’s Medical Advisory Board.
The information presented on this site is intended for educational purposes only. Neither the featured speakers, nor the Scleroderma Foundation, nor Starlight Productions ( the producers of these videos) suggest, recommend or endorse any specific treatment for any individual. Patients are advised consult their own health c
are providers for treatment options.
Back to Research Back to All Speakers
Back to All Topics